MedPath

palleos healthcare GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:4
Completed:2

Trial Phases

4 Phases

Phase 1:3
Phase 2:2
Phase 4:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (42.9%)
Phase 2
2 (28.6%)
Not Applicable
1 (14.3%)
Phase 4
1 (14.3%)

Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer During Chemotherapy in Combination With HER2-targeted Therapy or Antibody-drug Conjugate Therapy.

Not Applicable
Active, not recruiting
Conditions
Breast Cancer
First Posted Date
2022-06-21
Last Posted Date
2025-03-10
Lead Sponsor
Palleos Healthcare GmbH
Target Recruit Count
585
Registration Number
NCT05425550
Locations
🇨🇭

Seespital Horgen-Onkologie, Horgen, Switzerland

Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy with Atezolizumab - CTX Therapy

Phase 2
Completed
Conditions
Triple-negative Breast Cancer
Interventions
First Posted Date
2021-02-25
Last Posted Date
2024-11-04
Lead Sponsor
Palleos Healthcare GmbH
Target Recruit Count
416
Registration Number
NCT04770272
Locations
🇩🇪

Marienhospital Bottrop gGmbH; Klinik für Frauenheilkunde und Geburtshilfe;, Bottrop, Germany

Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy

Phase 4
Terminated
Conditions
Breast Neoplasm
Interventions
First Posted Date
2017-07-18
Last Posted Date
2022-01-06
Lead Sponsor
Palleos Healthcare GmbH
Target Recruit Count
532
Registration Number
NCT03220178
Locations
🇩🇪

University Hospital Mainz, Mainz, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.